Review Article

The Effect and Safety of 5-HT1F Receptor Agonist Lasmiditan on Migraine: A Systematic Review and Meta-Analysis

Figure 4

Forest plot: responder rate for pain freedom between different dosage comparisons at 2 h after the first dose.